Cargando…
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications
SIMPLE SUMMARY: Peritoneal carcinomatosis mouse models as a platform to test, improve and/or predict the appropriate therapeutic interventions in patients are crucial to providing medical advances. Here, we overview reported mouse models to explore peritoneal carcinomatosis in translational biomedic...
Autores principales: | Bella, Ángela, Di Trani, Claudia Augusta, Fernández-Sendin, Myriam, Arrizabalaga, Leire, Cirella, Assunta, Teijeira, Álvaro, Medina-Echeverz, José, Melero, Ignacio, Berraondo, Pedro, Aranda, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956655/ https://www.ncbi.nlm.nih.gov/pubmed/33669017 http://dx.doi.org/10.3390/cancers13050963 |
Ejemplares similares
-
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis
por: Bella, Ángela, et al.
Publicado: (2022) -
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis
por: Bella, Ángela, et al.
Publicado: (2023) -
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8(+) T cells eradicates peritoneal metastases in mouse models
por: Di Trani, Claudia Augusta, et al.
Publicado: (2022) -
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors
por: Tenesaca, Shirley, et al.
Publicado: (2021) -
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
por: Di Trani, Claudia Augusta, et al.
Publicado: (2023)